MX6752E - Procedimiento para preparar derivados de carboestirilos - Google Patents

Procedimiento para preparar derivados de carboestirilos

Info

Publication number
MX6752E
MX6752E MX808865U MX886580U MX6752E MX 6752 E MX6752 E MX 6752E MX 808865 U MX808865 U MX 808865U MX 886580 U MX886580 U MX 886580U MX 6752 E MX6752 E MX 6752E
Authority
MX
Mexico
Prior art keywords
carboestirile
derivatives
preparing
procedure
preparing carboestirile
Prior art date
Application number
MX808865U
Other languages
English (en)
Inventor
Takao Nishi
Tatsuyoshi Tanaka
Kazuyuki Nakagawa
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of MX6752E publication Critical patent/MX6752E/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
MX808865U 1980-02-29 1980-06-06 Procedimiento para preparar derivados de carboestirilos MX6752E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2565880A JPS56122356A (en) 1980-02-29 1980-02-29 Carbostyril derivative

Publications (1)

Publication Number Publication Date
MX6752E true MX6752E (es) 1986-06-25

Family

ID=12171902

Family Applications (1)

Application Number Title Priority Date Filing Date
MX808865U MX6752E (es) 1980-02-29 1980-06-06 Procedimiento para preparar derivados de carboestirilos

Country Status (24)

Country Link
US (1) US4435404A (es)
JP (1) JPS56122356A (es)
KR (2) KR860002099B1 (es)
AT (1) AT381493B (es)
AU (1) AU532319B2 (es)
BE (1) BE883713A (es)
CA (1) CA1159068A (es)
CH (1) CH647765A5 (es)
DE (1) DE3049959T1 (es)
DK (1) DK151956C (es)
ES (1) ES8105290A1 (es)
FI (1) FI76321C (es)
FR (1) FR2477149A1 (es)
GB (1) GB2070588B (es)
IT (1) IT1129812B (es)
MX (1) MX6752E (es)
NL (1) NL185146C (es)
NO (1) NO160512C (es)
PH (1) PH18532A (es)
PT (1) PT71359B (es)
SE (1) SE461147B (es)
SU (2) SU1169535A3 (es)
WO (1) WO1981002421A1 (es)
ZA (1) ZA803322B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578381A (en) * 1982-07-05 1986-03-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
DE3434271A1 (de) * 1984-09-19 1986-03-20 Beiersdorf Ag, 2000 Hamburg Substituierte 3,4-dihydro-chinolin-2(1h)-one verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
JP2753622B2 (ja) 1988-05-02 1998-05-20 大塚製薬株式会社 カルボスチリル誘導体
US5227381A (en) * 1988-05-02 1993-07-13 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative
WO1993004042A1 (fr) * 1991-08-23 1993-03-04 Otsuka Pharmaceutical Co., Ltd. Derive de carbostyrile et antiagregant plaquettaire
JP2686887B2 (ja) * 1992-08-11 1997-12-08 キッセイ薬品工業株式会社 ピペリジノ−3,4−ジヒドロカルボスチリル誘導体
US7208497B2 (en) 2001-07-02 2007-04-24 Novo Nordisk A/S Substituted piperazines and diazepanes
TWI481601B (zh) * 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物
EP2468733A4 (en) 2009-08-21 2013-02-06 Otsuka Pharma Co Ltd PROCESS FOR PRODUCING BENZO [B] [1,4] DIAZEPINE-2,4-DIONE COMPOUND

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1021522A (en) * 1963-05-10 1966-03-02 Ici Ltd 2-quinolone derivatives
DE1527937A1 (de) * 1966-12-10 1969-11-13 Blanc & Co Verfahren zur Herstellung eines sich konisch verjuengenden,einen nach aussen abgewinkelten flachen Rand aufweisenden Hohlteils sowie Einrichtung zur Durchfuehrung des Verfahrens
JPS517672B2 (es) * 1972-04-13 1976-03-10
JPS5082218A (es) * 1973-11-10 1975-07-03
JPS5310988B2 (es) * 1974-04-25 1978-04-18
JPS5318030B2 (es) * 1974-05-20 1978-06-13
FI59246C (fi) * 1974-06-24 1981-07-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin
US4313947A (en) 1974-06-24 1982-02-02 Otsuka Pharmaceutical Co., Ltd. Platelet aggregation inhibiting 2-oxyindoles, their compositions and method of use
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
JPS5273879A (en) * 1975-12-18 1977-06-21 Otsuka Pharmaceut Co Ltd Synthesis of ester derivatives
NZ187452A (en) * 1977-06-10 1980-05-27 Otsuka Pharma Co Ltd N- substituted-aminocarbonylpropoxy-carbostyrils and their preparation
JPS545981A (en) * 1977-06-10 1979-01-17 Otsuka Pharmaceut Co Ltd Carbostyryl derivatives

Also Published As

Publication number Publication date
ES492230A0 (es) 1981-05-16
KR840004681A (ko) 1984-10-22
BE883713A (fr) 1980-12-09
KR830002713A (ko) 1983-05-30
FI76321B (fi) 1988-06-30
FI76321C (fi) 1988-10-10
PT71359A (en) 1980-07-01
SU1395140A3 (ru) 1988-05-07
NO813477L (no) 1981-10-15
NL185146B (nl) 1989-09-01
AT381493B (de) 1986-10-27
AU532319B2 (en) 1983-09-22
PT71359B (en) 1981-10-21
NL185146C (nl) 1990-02-01
KR860002099B1 (ko) 1986-11-25
ES8105290A1 (es) 1981-05-16
DK250381A (da) 1981-09-03
DE3049959T1 (de) 1982-07-29
NO160512B (no) 1989-01-16
GB2070588A (en) 1981-09-09
DE3049959C2 (es) 1993-07-08
DK151956C (da) 1988-08-15
KR860002100B1 (ko) 1986-11-25
ZA803322B (en) 1982-01-27
JPS56122356A (en) 1981-09-25
US4435404A (en) 1984-03-06
IT1129812B (it) 1986-06-11
FR2477149B1 (es) 1983-06-24
SE461147B (sv) 1990-01-15
FR2477149A1 (fr) 1981-09-04
GB2070588B (en) 1983-10-19
PH18532A (en) 1985-08-09
AU5985980A (en) 1981-09-11
ATA909480A (de) 1986-03-15
DK151956B (da) 1988-01-18
NL8020199A (nl) 1981-12-01
NO160512C (no) 1989-04-26
IT8067888A0 (it) 1980-06-06
SE8102690L (sv) 1981-08-30
FI801843A (fi) 1981-08-30
SU1169535A3 (ru) 1985-07-23
JPS6334845B2 (es) 1988-07-12
WO1981002421A1 (en) 1981-09-03
CH647765A5 (de) 1985-02-15
CA1159068A (en) 1983-12-20

Similar Documents

Publication Publication Date Title
ES507715A0 (es) Procedimiento para preparar derivados de 1-sulfo-2-oxoazetidina .
ES516588A0 (es) Procedimiento para preparar derivados de piridona.
ES526827A0 (es) Procedimiento para preparar derivados de n-fenilpirazol
AR231137A1 (es) Procedimiento para preparar metoxifenetilimidazoles
ES502276A0 (es) Procedimiento para preparar derivados de piridoxina
ES505898A0 (es) Procedimiento para preparar derivados de pirimidona
MX161088A (es) Procedimiento para preparar derivados de 1-metil-5-p-tolilpirrol-2-acetamida
MX158198A (es) Procedimiento para preparar derivados de amidinopiperidina
ES504256A0 (es) Procedimiento para la obtencion de derivados de triazolil- propenol
ES539314A0 (es) Procedimiento para preparar derivados de n-fenilpirazol
MX157788A (es) Procedimiento para preparar derivados de oxima
ES502851A0 (es) Procedimiento para preparar n6-adenosina
ES524830A0 (es) Procedimiento para preparar derivados de xantina
MX6752E (es) Procedimiento para preparar derivados de carboestirilos
ES500738A0 (es) Procedimiento para preparar pirimidil-quinazolinas
ES500796A0 (es) Procedimiento para preparar derivados de pirimidona
ES527164A0 (es) Procedimiento para preparar derivados de 2-piperacinil-quinazolina
MX6807E (es) Procedimiento para preparar oxaquinolicidinas
MX6699E (es) Procedimiento para preparar acil-ureas
MX157614A (es) Procedimiento para preparar derivados de isohexido
ES521847A0 (es) Procedimiento para preparar derivados de pleuromutilina
AR226337A1 (es) Procedimiento para preparar kijanimicina
AR229509A1 (es) Procedimiento para preparar derivados de 2-halogeno-acetanilidas
ES503432A0 (es) Procedimiento para preparar derivados de genantreno
ES515767A0 (es) Procedimiento para preparar derivados de indano.